Drawing for VISION FOR A CURE

USPTO serial 77516850

VISION FOR A CURE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BULLOFF, TOBY ELLEN
Law office
OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VISION FOR A CURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bridget N. Amicone

PO BOX 19GUILDERLAND CENTER, NY 12085-0019UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Protective eyewearABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 16, 2009MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Apr 16, 2009ABN5ABANDONMENT - AFTER PUBLICATION—
Mar 31, 2009EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Dec 22, 2008ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 2, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2008NPUBNOTICE OF PUBLICATION—
Oct 24, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 24, 2008ALIEASSIGNED TO LIE—
Oct 15, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 15, 2008DOCKASSIGNED TO EXAMINER—
Jul 11, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance